NasdaqGS - Nasdaq Real Time Price USD

Cantaloupe, Inc. (CTLP)

Compare
9.25 -0.05 (-0.54%)
At close: December 13 at 4:00:02 PM EST
9.00 -0.25 (-2.70%)
After hours: December 13 at 7:16:55 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 70.84M
Earnings 3.28M
Q4'23
Q1'24
Q2'24
Q3'24
0
20M
40M
60M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

10.50
11.50 Average
9.25 Current
12.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2222
Avg. Estimate 0.070.110.360.51
Low Estimate 0.060.110.320.43
High Estimate 0.080.110.40.59
Year Ago EPS 0.060.10.250.36

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2025)Next Year (2026)
No. of Analysts 6666
Avg. Estimate 75.29M80.18M312.15M359.88M
Low Estimate 74.72M78.33M308.69M349.35M
High Estimate 75.8M82.3M317.4M367.6M
Year Ago Sales 65.36M67.9M268.6M312.15M
Sales Growth (year/est) 15.20%18.09%16.22%15.29%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. 0.040.070.050.04
EPS Actual 0.060.10.040.06
Difference 0.020.03-0.020.03
Surprise % 60.25%44.76%-29.27%72.08%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.070.110.360.51
7 Days Ago 0.070.110.360.51
30 Days Ago 0.070.120.360.51
60 Days Ago 0.070.120.360.51
90 Days Ago 0.060.10.330

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 1--2--
Up Last 30 Days 1--2--
Down Last 7 Days --1----
Down Last 30 Days --1----

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CTLP 9.20%8.56%43.31%41.67%
S&P 500 5.00%12.00%2.10%12.20%

Upgrades & Downgrades

Maintains Northland Capital Markets: Outperform to Outperform 11/11/2024
Maintains Barrington Research: Outperform to Outperform 11/8/2024
Maintains Benchmark: Buy to Buy 11/8/2024
Maintains Barrington Research: Outperform to Outperform 11/4/2024
Maintains Barrington Research: Outperform to Outperform 9/13/2024
Reiterates Benchmark: Buy to Buy 9/11/2024

Related Tickers